Axillary response rates to neoadjuvant chemotherapy in breast cancer patients with advanced nodal disease

被引：4

作者：

Goel, Neha ^{[1
]}

Yadegarynia, Sina ^{[1
]}

Rodgers, Steve ^{[1
]}

Kelly, Kristin ^{[1
]}

Collier, Amber ^{[1
]}

Franceschi, Dido ^{[1
]}

Moller, Mecker ^{[1
]}

Avisar, Eli ^{[1
]}

Kesmodel, Susan B. ^{[1
]}

机构：

[1] Univ Miami, Miller Sch Med, Dept Surg, Div Surg Oncol, Miami, FL 33136 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2021年 / 124卷 / 01期

基金：

美国国家卫生研究院;

关键词：

advanced nodal disease; axillary lymph node dissection; breast cancer; sentinel lymph node biopsy;

D O I：

10.1002/jso.26480

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose Utilization of sentinel lymph node biopsy (SLNB) in breast cancer patients with positive nodes after neoadjuvant chemotherapy (NAC) has increased. We examine axillary response rates after NAC in patients with clinical N2-3 disease to determine whether SLNB should be considered. Methods Breast cancer patients with clinical N2-3 (AJCC 7th Edition) disease who received NAC followed by surgery were selected from our institutional tumor registry (2009-2018). Axillary response rates were assessed. Results Ninety-nine patients with 100 breast cancers were identified: 59 N2 (59.0%) and 41 (41.0%) N3 disease; 82 (82.0%) treated with axillary lymph node dissection (ALND) and 18 (18.0%) SLNB. The majority (99.0%) received multiagent NAC. In patients undergoing ALND, cCR was observed in 20/82 patients (24.4%), pathologic complete response (pCR) in 15 patients (18.3%), and axillary pCR in 17 patients (20.7%). In patients with a cCR, pCR was identified in 60.0% and was most common in HER2+ patients (34.6%). Conclusion In this analysis of patients with clinical N2-3 disease receiving NAC, 79.3% of patients had residual nodal disease at surgery. However, 60.0% of patients with a cCR also had a pCR. This provides the foundation to consider evaluating SLNB and less extensive axillary surgery in this select group.

引用

页码：25 / 32

页数：8

共 32 条

[1] Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J].

Bear, HD ;

Anderson, S ;

Smith, RE ;

Geyer, CE ;

Mamounas, EP ;

Fisher, B ;

Brown, AM ;

Robidoux, A ;

Margolese, R ;

Kahlenberg, MS ;

Paik, S ;

Soran, A ;

Wickerham, DL ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2019-2027

[2] The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27 [J].

Bear, HD ;

Anderson, S ;

Brown, A ;

Smith, R ;

Mamounas, EP ;

Fisher, B ;

Margolese, R ;

Theoret, H ;

Soran, A ;

Wickerham, DL ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4165-4174

[3] Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study [J].

Boileau, Jean-Francois ;

Poirier, Brigitte ;

Basik, Mark ;

Holloway, Claire M. B. ;

Gaboury, Louis ;

Sideris, Lucas ;

Meterissian, Sarkis ;

Arnaout, Angel ;

Brackstone, Muriel ;

McCready, David R. ;

Karp, Stephen E. ;

Trop, Isabelle ;

Lisbona, Andre ;

Wright, Frances C. ;

Younan, Rami J. ;

Provencher, Louise ;

Patocskai, Erica ;

Omeroglu, Atilla ;

Robidoux, Andre .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) :258-U150

[4] Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance) [J].

Boughey, Judy C. ;

Ballman, Karla V. ;

Le-Petross, Huong T. ;

McCall, Linda M. ;

Mittendorf, Elizabeth A. ;

Ahrendt, Gretchen M. ;

Wilke, Lee G. ;

Taback, Bret ;

Feliberti, Eric C. ;

Hunt, Kelly K. .

ANNALS OF SURGERY, 2016, 263 (04) :802-807

[5] Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial [J].

Boughey, Judy C. ;

Suman, Vera J. ;

Mittendorf, Elizabeth A. ;

Ahrendt, Gretchen M. ;

Wilke, Lee G. ;

Taback, Bret ;

Leitch, A. Marilyn ;

Kuerer, Henry M. ;

Bowling, Monet ;

Flippo-Morton, Teresa S. ;

Byrd, David R. ;

Ollila, David W. ;

Julian, Thomas B. ;

McLaughlin, Sarah A. ;

McCall, Linda ;

Symmans, W. Fraser ;

Le-Petross, Huong T. ;

Haffty, Bruce G. ;

Buchholz, Thomas A. ;

Nelson, Heidi ;

Hunt, Kelly K. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1455-1461

[6] Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment [J].

Bufi, Enida ;

Belli, Paolo ;

Di Matteo, Marialuisa ;

Terribile, Daniela ;

Franceschini, Gianluca ;

Nardone, Luigia ;

Petrone, Gianluigi ;

Bonomo, Lorenzo .

EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (09) :1631-1638

[7] Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer [J].

Buzdar, AU ;

Ibrahim, NK ;

Francis, D ;

Booser, DJ ;

Thomas, ES ;

Theriault, RL ;

Pusztai, L ;

Green, MC ;

Arun, BK ;

Giordano, SH ;

Cristofanilli, M ;

Frye, DK ;

Smith, TL ;

Hunt, KK ;

Singletary, SE ;

Sahin, AA ;

Ewer, MS ;

Buchholz, TA ;

Berry, D ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3676-3685

[8] Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection [J].

Caudle, Abigail S. ;

Yang, Wei T. ;

Krishnamurthy, Savitri ;

Mittendorf, Elizabeth A. ;

Black, Dalliah M. ;

Gilcrease, Michael Z. ;

Bedrosian, Isabelle ;

Hobbs, Brian P. ;

DeSnyder, Sarah M. ;

Hwang, Rosa F. ;

Adrada, Beatriz E. ;

Shaitelman, Simona F. ;

Chavez-MacGregor, Mariana ;

Smith, Benjamin D. ;

Candelaria, Rosalind P. ;

Babiera, Gildy V. ;

Dogan, Basak E. ;

Santiago, Lumarie ;

Hunt, Kelly K. ;

Kuerer, Henry M. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1072-+

[9] Magnetic resonance imaging in breast cancer treated with neoadjuvant chemotherapy: Radiologic-pathologic correlation of the response and disease-free survival depending on molecular subtype [J].

Cruz Ciria, S. ;

Jimenez Aragon, F. ;

Garcia Mur, C. ;

Esteban Cuesta, H. ;

Gros Baneres, B. .

RADIOLOGIA, 2014, 56 (06) :524-532

[10] Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer [J].

Dominici, Laura S. ;

Gonzalez, Viviana M. Negron ;

Buzdar, Aman U. ;

Lucci, Anthony ;

Mittendorf, Elizabeth A. ;

Le-Petross, Huong T. ;

Babiera, Gildy V. ;

Meric-Bernstam, Funda ;

Hunt, Kelly K. ;

Kuerer, Henry M. .

CANCER, 2010, 116 (12) :2884-2889

← 1 2 3 4 →